Healthcare professionals are drowning in content—yet still struggle to stay current. From email fatigue to fragmented portals, the burden is real. Backed by Magnet4Europe data powered by Meplis, we explore why this matters and what HCPs really need to cut through the noise.
Despite billions invested, real-world evidence (RWE) still struggles to deliver lifecycle impact in Pharma and Medtech. Fragmented data, poor standards, and underuse in early R&D continue to limit ROI. Discover what’s needed to fix the system—and how smarter, connected RWE strategies can drive product success.
Post-market surveillance in pharma and medtech is overdue for transformation. Fragmented systems, manual workflows, and compliance barriers are slowing progress—while AI remains underutilized. Discover why smarter, AI-ready PMS strategies are becoming a competitive necessity.
Pharma and Medtech pour billions into targeted marketing, but HCP engagement keeps dropping. What’s going wrong? 🔍 Read more to uncover the key inefficiencies and smarter strategies for better results.
Pharma and Medtech companies invest billions in professional education, yet HCP engagement remains low. Fragmented industry portals, compliance restrictions, and lack of personalization are limiting impact. Discover the 10 biggest inefficiencies in industry-sponsored professional education—and how a smarter, data-driven approach can improve engagement and ROI.
Patient recruitment inefficiencies delay up to 85% of clinical trials, costing sponsors $600K–$8M per day. With less than 5% of eligible patients enrolling, recruitment remains a major challenge. Explore key insights and data-driven strategies to improve retention and accelerate trial success.
Pharma and medtech invest billions in clinical research, yet inefficiencies in site and investigator selection delay trials and inflate costs. Discover how AI-driven insights and real-time data can optimize trial site feasibility, improve patient recruitment, and accelerate time to market.
Pharma and medtech invested $238 billion in R&D in 2022—but inefficiencies in early-stage collaboration with HCPs and KOLs are driving costs up and slowing innovation. Discover how Meplis helps optimize R&D collaboration to maximize ROI.
Meplis is evolving to meet the needs of healthcare organizations and professionals. Our latest upgrade to Angular 16 enhances user experience, enables greater customization, and ensures our platform stays at the forefront of innovation. Explore what’s new!
Welcome to the New Meplis.com: Showcasing Our Full Range of Healthcare Technology and Services At Meplis, we have always focused..